Reuters: Regulatory News: SEC charges 8 men with insider trading around 2009 Sanofi deal

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

SEC charges 8 men with insider trading around 2009 Sanofi deal Aug 28th 2012, 19:27 Tue Aug 28, 2012 3:27pm EDT Aug 28 (Reuters) - U.S. securities regulators on Tuesday charged eight people with illegally trading on inside information in 2009 about French pharmaceutical company Sanofi's plan to buy a Tennessee-based company that made allergy medicine and other products. The men made more than $500,000 in illegal profits by trading on information about Sanofi's planned acquisition of Chattem Inc, the Securities and Exchange Commission said in a statement. Chattem produces the allergy medicine Allegra, skin care products such as Gold Bond, pain-relieving lotion IcyHot and other products. Regulators said a Georgia accountant received confidential information about the acquisition from a client who was on the board of directors at Chattem. The accountant tipped off friends, who traded on the information, and some passed the information along to others, the SEC said. Four of the men have agreed to settle the charges and pay back money made on the trades, plus interest and penalties, for a combined total of more than $175,000. One of the four will be blocked from practicing before the SEC as an accountant, regulators said. The SEC will continue its case against the other four men, according to the statement.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions